Skip to main content
Premium Trial:

Request an Annual Quote

Robert Friel, Peter Coggins, Aaron Geist, Janet Lankard, Elazar Rabbani, John Sias, Marcus Conant, Schott Nexterion, Genomatix Software


People in the News

Robert Friel has been named president of PerkinElmer's Life & Analytical Sciences business unit, the company said last week.

Friel will continue his roles of vice chairman and remains a member of its board of directors, PE said. He also serves on the boards of Millennium Pharmaceuticals and Fairchild Semiconductor.

Friel succeeds Peter Coggins, who will retire in February, but will continue to support the company as a senior advisor and consultant through mid-2007.

Separately, PerkinElmer last week also appointed Aaron Geist vice president of business development.

Geist was formerly director and senior research analyst at Robert W. Baird.

Janet Lankard has been named vice president of sales and technology collaborations at VisEn Medical, the imaging company said last week.

Lankard joins VisEn from Quantum Dot, where she served as vice president of sales and technical support. She also worked at Affymetrix from 1998 to 2004, where she worked first as a regional sales manager and later as director of sales and technical support for North America west. Before joining Affy, Lankard was an executive sales account manager at Applied Biosystems from 1991 to 1998.

Lankard holds a BSc in biochemistry from California Polytechnic University, San Luis Obispo.

Shareholders of Enzo Biochem elected three directors at Enzo's annual meeting this month.

Elazar Rabbani, Enzo's chairman, CEO, and founder, John Sias, the former president and CEO of Chronicle Publishing, and Marcus Conant, a clinical professor at the University of California, San Francisco, were all elected to 3-year terms, Enzo reported.

Sias and Conant have served on the Enzo board of directors since 1982 and 2004, respectively.

New Product Watch

Schott Nexterion last week launched its Nexterion HiSens microarray slides.

According to the company, the slides are coated with either epoxy or aminosilane on a borosilicate glass substrate, and are compatible with most microarray printing technology.

Schott recommended the slides for microarray applications "where the target material is at a low concentration or cannot be reliably amplified, such as applications measuring mRNAs or low abundant proteins."

Genomatix Software said last week that it will launch ChipInspector ExonArray, a new version of the firm's ChipInspector software specifically geared towards analysis of the exon arrays, at the beginning of the second quarter.

According to Genomatix, ChipInspector ExonArray will improve analysis of exon array data, including transcript separation and promoter identification of the relevant transcripts.

The company is now accepting preorders from existing ChipInspector customers


A recent story about CombiMatrix's new line of microRNA arrays may have misled some readers with regards to the price of those arrays. CombiMatrix's miRNA arrays sell for $99 per array, with four arrays available on each chip — making the price of an miRNA chip from CombiMatrix roughly $400 (see BAN 1/10/2006).

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.